News
Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Agilent Technologies, Inc. (NYSE:A) and set a price target of ...
On May 29, 2025, Stifel analysts reiterated their Buy rating and $550 price target for Synopsys, Inc. (NASDAQ:SNPS) shares.
On May 24, analysts at Stifel reaffirmed their Buy rating and price target of $48 for Bicara Therapeutics Inc. (NASDAQ:BCAX).
and on Friday a three-person arbitration panel ruled Stifel Nicolaus & Co. Inc. pay $7 million in legal costs of advisors who left the firm in 2023 and then were sued by the firm. It’s the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results